Gene · 57697
Papers1,618
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,618
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Fanconi anemia core complex promotes CtIP-dependent end resection to drive homologous recombination at DNA double-strand breaks. | Nat Commun | 2024 | 39152113 | PubTator, text mining | PubMed |
| Accuracy of renovo predictions on variants reclassified over time. | J Transl Med | 2024 | 39085881 | PubTator, text mining | PubMed |
| Prospective genetic germline evaluation in a consecutive group of adult patients aged <60 years with myelodysplastic syndromes. | Hemasphere | 2024 | 39015540 | PubTator, text mining | PubMed |
| RNA biogenesis and RNA metabolism factors as R-loop suppressors: a hidden role in genome integrity. | Genes Dev | 2024 | 38986581 | PubTator, text mining | PubMed |
| FANCM promotes PARP inhibitor resistance by minimizing ssDNA gap formation and counteracting resection inhibition. | Cell Rep | 2024 | 38985669 | PubTator, text mining | PubMed |
| [Homozygous Variant of FANCM of the Fanconi Anemia Pathway Causes Premature Ovarian Insufficiency: Investigation of the Pathogenic Mechanism]. | Sichuan Da Xue Xue Bao Yi Xue Ban | 2024 | 38948269 | PubTator, text mining | PubMed |
| PCAF promotes R-loop resolution via histone acetylation. | Nucleic Acids Res | 2024 | 38936834 | PubTator, text mining | PubMed |
| FANCM Gene Variants in a Male Diagnosed with Sertoli Cell-Only Syndrome and Diffuse Astrocytoma. | Genes (Basel) | 2024 | 38927643 | PubTator, text mining | PubMed |
| FANCM branchpoint translocase: Master of traverse, reverse and adverse DNA repair. | DNA Repair (Amst) | 2024 | 38878565 | PubTator, text mining | PubMed |
| Discovery of NSD2 non-histone substrates and design of a super-substrate. | Commun Biol | 2024 | 38851815 | PubTator, text mining | PubMed |
| Crucial role of the NSE1 RING domain in Smc5/6 stability and FANCM-independent fork progression. | Cell Mol Life Sci | 2024 | 38847937 | PubTator, text mining | PubMed |
| Clinical actionability of BRCA2 alterations in uterine leiomyosarcoma: a molecular tumor board case report and a cBioPortal comprehensive analysis. | Oncologist | 2024 | 38716772 | PubTator, text mining | PubMed |
| Predictive medicine in a testis trio-family through a combined multi-omics approach. | Clin Transl Med | 2024 | 38616705 | PubTator, text mining | PubMed |
| Diverse genetic causes of amenorrhea in an ethnically homogeneous cohort and an evolving approach to diagnosis. | Mol Cell Endocrinol | 2024 | 38521400 | PubTator, text mining | PubMed |
| A scalable platform for efficient CRISPR-Cas9 chemical-genetic screens of DNA damage-inducing compounds. | Sci Rep | 2024 | 38291084 | PubTator, text mining | PubMed |
| FLIP(C1orf112)-FIGNL1 complex regulates RAD51 chromatin association to promote viability after replication stress. | Nat Commun | 2024 | 38286805 | PubTator, text mining | PubMed |
| SMC5/6 Promotes Replication Fork Stability via Negative Regulation of the COP9 Signalosome. | Int J Mol Sci | 2024 | 38256025 | PubTator, text mining | PubMed |
| Molecular Tumor Board Improves Outcomes for Hispanic Patients With Advanced Solid Tumors. | JCO Glob Oncol | 2024 | 38237094 | PubTator, text mining | PubMed |
| ATR inhibition using gartisertib enhances cell death and synergises with temozolomide and radiation in patient-derived glioblastoma cell lines. | Oncotarget | 2024 | 38227740 | PubTator, text mining | PubMed |
| Genomic and transcriptomic analysis of breast cancer identifies novel signatures associated with response to neoadjuvant chemotherapy. | Genome Med | 2024 | 38217005 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57697/papers?page=5